These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Cannabinoid Receptor Type 1 in the Brain Regulates the Affective Component of Visceral Pain in Mice. Bajic D; Monory K; Conrad A; Maul C; Schmid RM; Wotjak CT; Stein-Thoeringer CK Neuroscience; 2018 Aug; 384():397-405. PubMed ID: 29885522 [TBL] [Abstract][Full Text] [Related]
27. CB1 receptors in the formation of the different phases of memory-related processes in the inhibitory avoidance test in mice. Kruk-Slomka M; Biala G Behav Brain Res; 2016 Mar; 301():84-95. PubMed ID: 26711911 [TBL] [Abstract][Full Text] [Related]
28. Context-dependent effects of CB1 cannabinoid gene disruption on anxiety-like and social behaviour in mice. Haller J; Varga B; Ledent C; Barna I; Freund TF Eur J Neurosci; 2004 Apr; 19(7):1906-12. PubMed ID: 15078564 [TBL] [Abstract][Full Text] [Related]
29. Genetic deletion of dopamine D1 receptors increases the sensitivity to cannabinoid CB1 receptor antagonist-precipitated withdrawal when compared with wild-type littermates: studies in female mice repeatedly exposed to the Spice cannabinoid HU-210. Serrano A; Vadas E; Ferrer B; Bilbao A; Granado N; Suárez J; Pavon FJ; Moratalla R; Rodríguez de Fonseca F Psychopharmacology (Berl); 2021 Feb; 238(2):551-557. PubMed ID: 33410990 [TBL] [Abstract][Full Text] [Related]
30. Interactions between CB1 cannabinoid and mu opioid receptors mediating inhibition of neurotransmitter release in rat nucleus accumbens core. Schoffelmeer AN; Hogenboom F; Wardeh G; De Vries TJ Neuropharmacology; 2006 Sep; 51(4):773-81. PubMed ID: 16806307 [TBL] [Abstract][Full Text] [Related]
31. Genetic dissection of behavioural and autonomic effects of Delta(9)-tetrahydrocannabinol in mice. Monory K; Blaudzun H; Massa F; Kaiser N; Lemberger T; Schütz G; Wotjak CT; Lutz B; Marsicano G PLoS Biol; 2007 Oct; 5(10):e269. PubMed ID: 17927447 [TBL] [Abstract][Full Text] [Related]
32. Cannabinoid CB1 receptor antagonism reduces conditioned reinstatement of ethanol-seeking behavior in rats. Cippitelli A; Bilbao A; Hansson AC; del Arco I; Sommer W; Heilig M; Massi M; Bermúdez-Silva FJ; Navarro M; Ciccocioppo R; de Fonseca FR; Eur J Neurosci; 2005 Apr; 21(8):2243-51. PubMed ID: 15869521 [TBL] [Abstract][Full Text] [Related]
33. The cannabinoid CB1 receptor antagonist SR 141716A induces penile erection by increasing extra-cellular glutamic acid in the paraventricular nucleus of male rats. Succu S; Mascia MS; Sanna F; Melis T; Argiolas A; Melis MR Behav Brain Res; 2006 May; 169(2):274-81. PubMed ID: 16516985 [TBL] [Abstract][Full Text] [Related]
34. Distribution of type 1 cannabinoid receptor-expressing neurons in the septal-hypothalamic region of the mouse: colocalization with GABAergic and glutamatergic markers. Hrabovszky E; Wittmann G; Kalló I; Füzesi T; Fekete C; Liposits Z J Comp Neurol; 2012 Apr; 520(5):1005-20. PubMed ID: 21935941 [TBL] [Abstract][Full Text] [Related]
35. Cannabinoid CB1 receptor in dorsal telencephalic glutamatergic neurons: distinctive sufficiency for hippocampus-dependent and amygdala-dependent synaptic and behavioral functions. Ruehle S; Remmers F; Romo-Parra H; Massa F; Wickert M; Wörtge S; Häring M; Kaiser N; Marsicano G; Pape HC; Lutz B J Neurosci; 2013 Jun; 33(25):10264-77. PubMed ID: 23785142 [TBL] [Abstract][Full Text] [Related]
36. Striatal GABAergic and cortical glutamatergic neurons mediate contrasting effects of cannabinoids on cortical network synchrony. Sales-Carbonell C; Rueda-Orozco PE; Soria-Gómez E; Buzsáki G; Marsicano G; Robbe D Proc Natl Acad Sci U S A; 2013 Jan; 110(2):719-24. PubMed ID: 23269835 [TBL] [Abstract][Full Text] [Related]
37. The central cannabinoid CB1 receptor is required for diet-induced obesity and rimonabant's antiobesity effects in mice. Pang Z; Wu NN; Zhao W; Chain DC; Schaffer E; Zhang X; Yamdagni P; Palejwala VA; Fan C; Favara SG; Dressler HM; Economides KD; Weinstock D; Cavallo JS; Naimi S; Galzin AM; Guillot E; Pruniaux MP; Tocci MJ; Polites HG Obesity (Silver Spring); 2011 Oct; 19(10):1923-34. PubMed ID: 21799481 [TBL] [Abstract][Full Text] [Related]
38. Opposite control of frontocortical 2-arachidonoylglycerol turnover rate by cannabinoid type-1 receptors located on glutamatergic neurons and on astrocytes. Belluomo I; Matias I; Pernègre C; Marsicano G; Chaouloff F J Neurochem; 2015 Apr; 133(1):26-37. PubMed ID: 25626460 [TBL] [Abstract][Full Text] [Related]
39. Glutamate spillover drives endocannabinoid production and inhibits GABAergic transmission in the Substantia Nigra pars compacta. Freestone PS; Guatteo E; Piscitelli F; di Marzo V; Lipski J; Mercuri NB Neuropharmacology; 2014 Apr; 79():467-75. PubMed ID: 24334069 [TBL] [Abstract][Full Text] [Related]
40. Blockade by the cannabinoid CB1 receptor antagonist, rimonabant (SR141716), of the potentiation by quinelorane of food-primed reinstatement of food-seeking behavior. Duarte C; Alonso R; Bichet N; Cohen C; Soubrié P; Thiébot MH Neuropsychopharmacology; 2004 May; 29(5):911-20. PubMed ID: 14694354 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]